TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC COCHLEAR IMPLANTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 VENDOR SHARE ANALYSIS
2.8 MULTIVARIATE MODELING
2.9 PRODUCTS LIFELINE CURVE
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING AWARENESS TOWARDS HEARING AIDS
5.1.2 TECHNOLOGICAL ADVANCEMENTS IN MAKING EFFICIENT DEVICES WITH INCREASED BATTERY LIFE
5.1.3 ADEQUATE REIMBURSEMENT SCENARIO
5.1.4 INCREASING NUMBER OF CASES OF HEARING LOSS
5.1.5 GROWING NUMBER OF HEARING AID CLINICS
5.2 RESTRAINTS
5.2.1 HIGH COST OF IMPLANTS
5.2.2 DEARTH OF SKILLED PROFESSIONAL
5.2.3 POST IMPLANTS COMPLICATIONS INCLUDING FACIAL PARALYSIS, POST-OPERATIVE SENSE OF IMBALANCE AND DAMAGE TO NERVES
?
5.3 OPPORTUNITIES
5.3.1 INTRODUCTION OF INNOVATIVE PRODUCT IN THE MARKET
5.3.2 INCREASING GOVERNMENT AND NON-GOVERNMENT INITIATIVE.
5.3.3 IMPROVED OUTCOMES LEADS TO EXPANSION OF INDICATION
5.3.4 UNMET AND UNADDRESSABLE CLINICAL NEED FOR COCHLEAR IMPLANT ACROSS THE GLOBE
5.4 CHALLENGES
5.4.1 MANUAL AND LABOR INTENSIVE PRODUCTION
5.4.2 NEED FOR LONG-TERM IMPLANTABLE AND RECHARGEABLE BATTERIES, CONNECTORS AND SAFETY
6 ASIA-PACIFIC COCHLEAR IMPLANTS MARKET, BY TYPE
6.1 OVERVIEW
6.2 PRODUCT
6.3 ACCESSORIES
6.4 SOFTWARE
7 ASIA-PACIFIC COCHLEAR IMPLANTS MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ELECTRO-ACOUSTIC STIMULATION (EAS)
7.3 ACOUSTIC AMPLIFICATION TECHNOLOGY
7.4 ELECTRO-STIMULATION TECHNOLOGY
8 ASIA-PACIFIC COCHLEAR IMPLANTS MARKET, BY AGE
8.1 OVERVIEW
8.2 ADULTS
8.2.1 BILATERAL IMPLANTATION
8.2.2 UNILATERAL IMPLANTATION
8.3 PEDIATRICS
8.3.1 BILATERAL IMPLANTATION
8.3.2 UNILATERAL IMPLANTATION
9 ASIA-PACIFIC COCHLEAR IMPLANTS MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITAL
9.3 ENT CLINICS
9.4 AMBULATORY SURGERY CENTER
10 ASIA-PACIFIC COCHLEAR IMPLANTS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT
10.3 RETAIL
11 ASIA-PACIFIC COCHLEAR IMPLANTS MARKET, BY GEOGRAPHY
11.1 ASIA-PACIFIC
11.1.1 CHINA
11.1.2 JAPAN
11.1.3 INDIA
11.1.4 SOUTH KOREA
11.1.5 AUSTRALIA
11.1.6 SINGAPORE
11.1.7 THAILAND
11.1.8 MALAYSIA
11.1.9 INDONESIA
11.1.10 PHILIPPINES
11.1.11 REST OF ASIA-PACIFIC
12 ASIA-PACIFIC COCHLEAR IMPLANTS MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 COMPANY PROFILES
13.1 COCHLEAR LTD.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 ADVANCED BIONICS AG (A SUBSIDIARY OF SONOVA)
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 SOLUTION PORTFOLIO
13.2.5 RECENT DEVELOPMENT
13.3 MED-EL MEDICAL ELECTRONICS
13.3.1 COMPANY SNAPSHOT
13.3.2 COMPANY SHARE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENTS
13.4 MEDTRONIC
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT DEVELOPMENT
13.5 NUROTRON BIOTECHNOLOGY CO. LTD.
13.5.1 COMPANY SNAPSHOT
13.5.2 PRODUCT PORTFOLIO
13.5.3 RECENT DEVELOPMENTS
13.6 OTICON A/S
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 WIDEX A/S
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 RELATED REPORTS